Paramita Chakraborty to Cell Line, Tumor
This is a "connection" page, showing publications Paramita Chakraborty has written about Cell Line, Tumor.
Connection Strength
0.271
-
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells. J Biol Chem. 2019 06 07; 294(23):9198-9212.
Score: 0.116
-
Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate. J Leukoc Biol. 2012 Apr; 91(4):609-19.
Score: 0.070
-
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
Score: 0.028
-
Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control. Oncotarget. 2016 Oct 25; 7(43):69371-69383.
Score: 0.024
-
Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer. Biochimie. 2012 Jan; 94(1):166-83.
Score: 0.017
-
Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate. PLoS One. 2010 Jun 22; 5(6):e11253.
Score: 0.016